Towa Pharmaceutical Co., Ltd. (TYO:4553)
3,495.00
-75.00 (-2.10%)
Oct 2, 2026, 3:30 PM JST
Towa Pharmaceutical Market Cap
Towa Pharmaceutical has a market cap or net worth of 172.05 billion as of October 2, 2026. Its market cap has increased by 19.69% in one year.
Market Cap
172.05B
Enterprise Value
359.75B
Revenue
279.94B
Ranking
n/a
PE Ratio
20.81
Stock Price
3,495.00
ChartMarket Cap Chart
Since January 20, 1995, Towa Pharmaceutical's market cap has increased from 104.94B to 172.05B, an increase of 63.95%. That is a compound annual growth rate of 1.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 172.05B | -3.98% |
| Dec 30, 2025 | 179.19B | 8.50% |
| Dec 30, 2024 | 165.16B | 42.67% |
| Dec 29, 2023 | 115.76B | 10.36% |
| Dec 30, 2022 | 104.89B | -25.58% |
| Dec 30, 2021 | 140.95B | 49.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sumitomo Pharma | 723.81B |
| Tsumura & Co. | 276.04B |
| Nippon Shinyaku | 227.68B |
| Sawai Group Holdings | 183.82B |
| Kissei Pharmaceutical | 153.09B |
| Kaken Pharmaceutical | 142.95B |
| Mochida Pharmaceutical | 108.96B |
| Zeria Pharmaceutical | 83.66B |